↓ Skip to main content

Mitoxantrone for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
214 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mitoxantrone for multiple sclerosis
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd002127.pub3
Pubmed ID
Authors

Filippo Martinelli Boneschi, Laura Vacchi, Marco Rovaris, Ruggero Capra, Giancarlo Comi

Abstract

This is an updated Cochrane review of the previous published version.Mitoxantrone (MX) has been shown to be moderately effective in reducing the clinical outcome measures of disease activity in multiple sclerosis (MS) patients.

Mendeley readers

The data shown below were compiled from readership statistics for 214 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 <1%
South Africa 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Colombia 1 <1%
Unknown 207 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 37 17%
Student > Master 32 15%
Researcher 32 15%
Student > Ph. D. Student 29 14%
Other 13 6%
Other 40 19%
Unknown 31 14%
Readers by discipline Count As %
Medicine and Dentistry 93 43%
Neuroscience 12 6%
Agricultural and Biological Sciences 12 6%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Biochemistry, Genetics and Molecular Biology 9 4%
Other 41 19%
Unknown 37 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2015.
All research outputs
#1,349,941
of 12,101,174 outputs
Outputs from Cochrane database of systematic reviews
#2,852
of 7,978 outputs
Outputs of similar age
#17,646
of 140,105 outputs
Outputs of similar age from Cochrane database of systematic reviews
#38
of 127 outputs
Altmetric has tracked 12,101,174 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 140,105 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 127 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.